Your browser doesn't support javascript.
loading
In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
Allemandi, D A; Alovero, F L; Manzo, R H.
Affiliation
  • Allemandi DA; Departamento de Farmacia, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina.
J Antimicrob Chemother ; 34(2): 261-5, 1994 Aug.
Article in En | MEDLINE | ID: mdl-7814287
Two new quinolones, NSFQ-104 and NSFQ-105, derivatives of ciprofloxacin and norfloxacin with a 4-(4-aminophenylsulphonyl)-1-piperazinyl at position 7 showed better in-vitro activity against strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus than ciprofloxacin or norfloxacin. Their in-vitro activity was enhanced at pH 5.5.
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcus aureus / Quinolones / Fluoroquinolones / Anti-Infective Agents Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 1994 Document type: Article Affiliation country: Argentina Country of publication: United kingdom
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcus aureus / Quinolones / Fluoroquinolones / Anti-Infective Agents Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 1994 Document type: Article Affiliation country: Argentina Country of publication: United kingdom